Professor Greg Irving

Profile

Biography

Greg is an academic General Practitioner with an interest in primary care research focusing on multiple long-term conditions and service delivery. He completed his medical training in Nottingham before going on to postgraduate studies at Oxford and Liverpool, then worked as a Clinical Lecturer in Cambridge. He has also previously studied as a Global Clinical Scholar at Harvard University. He has received three consecutive personal National Institute for Health Research (NIHR) Fellowships. He has secured external grant funding of over £9 million and has consistently featured in the Stanford World Top 1% of scientists in his field. His work has contributed to over 70 policy reports on primary care across 30 organisations, including the WHO, OECD, European Observatory, World Bank, and NICE. Greg works as a General Practitioner and Consultant in Primary Care in St Helens. He leads an NIHR Primary Care Reseach Hub in his practice. 

Research Interests

Greg is Director of the Health Research Institute and Director of the Edge Hill Primary and Integrated Care (EPIC). Greg’s research interests have focused on developing and evaluating complex interventions for use in primary care. He has experience in systematic reviews, randomised trials, observational studies along with qualitative research approaches. He has experience of working with large dataset including UK BioBank, CPRD and routine health and social data. Greg is the Deputy Lead for the NIHR North West Coast Complex Intervention Theme. Greg currently supervises two NIHR North West Coast Applied Research Collaboration PhD studentships (Anna Evans and Lucy Kaluvu) focusing multimorbidity and health care use.  

Teaching

Greg is a Fellow of the Academy of Medical Educators. He leads the complexity and uncertainty theme on the MBChB at Edge Hill Medical School. His medical education interests reflect those of his research interests and in addition have focused on Deep End General Practice, global health, workplace based training and role modelling.

• Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
• Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care
• Psychometric and biomedical outcomes of glycated haemoglobin target-setting in adults with type 1 and type 2 diabetes
• Metformin in non-diabetic hyperglycaemia
• International variations in primary care physician consultation time

• NIHR Clinical Lectureship in General Practice
• NIHR Doctoral Research Fellowship (DRF-2010-03-66) £339,763

• Yvonne Carter award for Primary Care Research
• Yvonne Carter award for Primary Care Research , RCGP / SAPC John Fry award